Serotonin and anxiety: current models
The DOI matches its Crossref record.
Abstract
Evidence for the importance of the serotonin system in anxiety disorders has increased substantially in recent years. Although preclinical research has provided an important source of hypotheses, clinical work on the value of selective serotonin reuptake inhibitors (SSRIs) in these conditions has been particularly persuasive. In this paper, a number of models of serotonin in the anxiety disorders are reviewed, and the clinical advantages of the SSRIs in anxiety disorders are emphasized. Models of serotonin in anxiety disorders include: 1) a 'see-saw model'; 2) an 'amygdala model'; and 3) a 'basal ganglia model'. While any simplistic schema in this complex area must fail, these various models have some heuristic value for the clinician. From a clinical perspective, the availability of the SSRIs has proved a significant step forward in the treatment of the anxiety disorders such as panic disorder, obsessive-compulsive disorder, post-traumatic stress disorder, and social anxiety disorder (social phobia); certainly these agents offer several advantages over previously existing pharmacotherapeutic alternatives such as the benzodiazepines and tricyclic antidepressants.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Holmes, A., Yang, R. J., Lesch, K.-P., Crawley, J. N., & Murphy, D. L. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300266 · Cited by 315
Holmes, A., Li, Q., Murphy, D. L., Gold, E., & Crawley, J. N. (2003) · Genes, Brain and Behavior · doi:10.1046/j.1601-1848.2003.00050.x · Cited by 313
Lower Serotonin Transporter Binding Potential in the Human Brain During Major Depressive Episodes
Parsey, R. V., Hastings, R. S., Oquendo, M. A., Huang, Y.-Y., Simpson, N., Arcement, J., Huang, Y., Ogden, R. T., Van Heertum, R. L., Arango, V., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.52 · Cited by 309
A regulatory variant of the human tryptophan hydroxylase-2 gene biases amygdala reactivity
Brown, S. M., Peet, E., Manuck, S. B., Williamson, D. E., Dahl, R. E., Ferrell, R. E., & Hariri, A. R. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001716 · Cited by 241
Burghardt, N. S., Bush, D. E. A., McEwen, B. S., & LeDoux, J. E. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.11.023 · Cited by 179
“Selective serotonin reuptake inhibitors (SSRIs) are commonly prescribed to treat depression (Bondareff et al 2000; Stahl 2000) as well as a range of anxiety disorders, such as panic disorder, obsessive compulsive disorder, post-traumatic stress disorder, and social anxiety disorder (Kent et al 1998; Pollack and Doyle…”
Background
Metadata
- Authors
- Stein, D. J., & Stahl, S.
- Venue
- International Clinical Psychopharmacology
- Published
- 2000-08
- Volume
- 15
- Pages
- S1-S6
- ISSN
- 0268-1315 (ISSN-L)
- OpenAlex
- W2160412201
- Cited by
- 68
- References
- 0
- FWCI
- 4.22
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Serotonin and anxiety: current models. https://app.cochat.ai/papers/10.1097/00004850-200008002-00002
- The paper
- Stein, D. J., & Stahl, S. (2000). Serotonin and anxiety: current models. International Clinical Psychopharmacology. https://doi.org/10.1097/00004850-200008002-00002
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.